An (1)H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

Cytarabine, the 4-amino-1-(β-D-arabinofuranosyl)-2(1H)-pyrimidinone, (ARA-C) is an antimetabolite cytidine analogue used worldwide as key drug in the management of leukaemia. As specified in the manufacturers’ instructions, once the components—sterile water and cytarabine powder—are unpackaged and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerchione, Claudio, Martinelli, Giovanni, Pedatella, Silvana, De Nisco, Mauro, Pugliese, Novella, Manfra, Michele, Marra, Nicoletta, Ronconi, Sonia, De Giorgi, Ugo, Altini, Mattia, Simonetti, Giorgia, Di Rorà, Andrea Ghelli Luserna, Bravaccini, Sara, Catalano, Lucio, Dora Iula, Vita, Pagano, Francesco, Picardi, Marco, Bolognese, Adele, Pane, Fabrizio, Martinelli, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903421/
https://www.ncbi.nlm.nih.gov/pubmed/31633499
http://dx.doi.org/10.1097/CAD.0000000000000850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903421/
https://www.ncbi.nlm.nih.gov/pubmed/31633499
http://dx.doi.org/10.1097/CAD.0000000000000850

Ejemplares similares